Navigation Links
Isis Reports Financial Results and Highlights for First Quarter 2012
Date:5/8/2012

60; Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, developing and commercializing drugs that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.  Isis' forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements.  Although Isis' forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Isis.  As a result, you are cautioned not to rely on these forward-looking statements.  These and other risks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2011, which is on file with the SEC. Copies of this and other documents are available from the Company.

In this press release, unless the context requires otherwise, "Isis," "Company," "we," "our," and "us" refers to Isis Pharmaceuticals and its subsidiaries, including Regulus Therapeutics Inc., its jointly owned subsidiary.

Isis Pharmaceuticals® is a registered trademark of Isis Pharmaceuticals, Inc.  Regulus Therapeutics™ is a trademark of Regulus Therapeutics Inc.  KYNAMRO™ is a trademark of Genzyme Corporation.ISIS PHARMACEUTICALS, INC.SELECTED FINANCIAL INFORMATIONCondensed Consolidated Statements of Operations(In Thousands, Except Per Share Data)Three months ended,March 31,20122011Revenue:(unaudited)Research and development revenueunder collaborative agreements$21,818
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Vanda Pharmaceuticals Reports First Quarter 2012 Results
2. Landauer, Inc. Reports Fiscal 2012 Second Quarter Results
3. Halozyme Reports First Quarter 2012 Financial Results
4. MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
5. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
6. IRIDEX Reports 2012 First Quarter Results
7. Cambrex Reports First Quarter 2012 Results
8. Cadence Pharmaceuticals Reports First Quarter 2012 Financial Results
9. Cumberland Pharmaceuticals Reports First Quarter 2012 Financial Results
10. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
11. Neuland Labs Reports Financial Results For Fiscal Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 26, 2014   Royal Philips ... today announced expanded availability of its portfolio of ... MobileDiagnost wDR, MobileDiagnost Opta[i] , ProGrade and PrimaryDiagnost[ii]. ... now available in the U.S., and availability of ... portfolio offers Philips, customers innovative solutions designed to ...
(Date:11/26/2014)... , Nov. 26, 2014 Lexicon ... announced the completion of previously announced concurrent financing ... After fees and estimated offering expenses, Lexicon anticipates ... transactions.  The transactions consisted of: , ... stock, pursuant to a registration statement that has ...
(Date:11/26/2014)... LOUIS , Nov. 26, 2014 Scott Steiger ... seen most of the world. As an engineer for the past ... a member of the military service. He,s been to six of ... Photo - http://photos.prnewswire.com/prnh/20141126/161076 Photo - ... specifically for travelers, he has a pretty good idea of what,s ...
Breaking Medicine Technology:Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3Lexicon Announces Completion Of $280 Million In Financing Transactions 2Lexicon Announces Completion Of $280 Million In Financing Transactions 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2
... Oct. 21 Reportlinker.com announces that a new market research report ... Market http://www.reportlinker.com/p0316091/Indian-Bulk-Drug-Market.html Indian bulk ... Indian Bulk Drug industry is expected to grow at ... per a Cygnus study. Cygnus estimates the size of Indian bulk ...
... Diplomat Specialty Pharmacy, the nation,s largest privately owned specialty ... innovative, web based tool designed to educate and train ... educational programs is the immediate focus of Jennifer Hagerman, ... Education and reports directly to Jeff Rowe, Senior Vice ...
Cached Medicine Technology:Reportlinker Adds Indian Bulk Drug Market 2Reportlinker Adds Indian Bulk Drug Market 3Reportlinker Adds Indian Bulk Drug Market 4Reportlinker Adds Indian Bulk Drug Market 5Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor 2
(Date:11/28/2014)... November 29, 2014 Angelweddingdress.com, a ... new collection of Blue Color Styles ... provided: up to 80% off and free shipping ... buy discounted blue bridesmaid dresses for less at ... , Angelweddingdress.com is famous as a reliable dress ...
(Date:11/28/2014)... Yesterday on November 27th, 2014, Thanksgiving morning, Branches ... families from 8 different sites throughout Miami-Dade and Broward ... Florida on Thanksgiving Day. Over 1,400 volunteers worked very ... individual meals via assembly lines and passing them off ... turkey, stuffing, green beans, mashed potatoes, cranberry sauce, a ...
(Date:11/28/2014)... Pathways Home Health & Hospice is joining ... was created to encourage people to take action and ... causes. This online event, celebrated the Tuesday after ... holiday shopping season. #GivingTuesday is to charitable giving as ... to online commerce. , The goal of #GivingTuesday is ...
(Date:11/28/2014)... York, NY (PRWEB) November 28, 2014 ... cash-for-junk-cars companies, is expanding their service offerings to help ... York City, Philadelphia and Washington, D.C. metropolitan areas deal ... to sweep across a large part of the country. ... these areas resulting in hundreds of totaled, crashed and ...
(Date:11/28/2014)... York, New York (PRWEB) November 28, 2014 ... are continuing to move forward in New Jersey’s ... claims in a consolidated litigation established there is ... Case List updated on November 18th shows 1,293 ... was created for lawsuits that allege complications resulting ...
Breaking Medicine News(10 mins):Health News:Blue Color Styles of Bridesmaid Dresses from AngelWeddingDress.com are Available Now With Big Discounts 2Health News:Branches’ 14th Annual Thanksgiving Delivers 6,000+ Meals to Families in Need 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Junk-A-Car Expanding Service to Assist U.S. Car Owners That May be Affected by Severe Winter Storms 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Nearly 1,300 Mirena Lawsuits Now Filed in Consolidated New Jersey Litigation, Bernstein Liebhard LLP Reports 3
... Group NV together with the University of Cologne (DE) ... adult mesenchymal stem cells ("MSCs") from the lining ... the collection and cryopreservation of very high quantities of ... ,Mesenchymal stem cells (MSCs) are of great therapeutic potential ...
... the most common addiction all over the world, and a ... impact of tobacco in its various forms on human health, ... smoking. ,Tobacco generates about Rs.7,964 crore ... about Rs.27,661 crore, according to WHO estimates. ...
... therapies - combining two or more medications into ... options for pharmaceutical brand teams to pursue ... Information's report "Pharmaceutical Product Relaunch: Preserving Market Share ... reveals that 58% of companies that launch combination ...
... Calum Best has decided to enter rehab in order to get ... ,Calum, who was recently snapped in a sleazy romp ... bad stuffs. ,"Im a bad boy. I go ... do stupid debauched things with the wrong women. Ive been sowing ...
... provide oral cancer examinations for their patients, but many ... optimum intervals, according to a new study. ,With ... and of proper examination techniques, some dentists in Illinois ... detect oral cancers in their patients," said Charles LeHew ...
... have created a synthetic polymer that doesnt burn, making it ... so flammable they are sometimes referred to as solid ... chemicals that are added to many plastics before they can ... items. Some of these additives have been showing up in ...
Cached Medicine News:Health News:Significant Scientific Breakthrough in Stem Cell Banking 2Health News:Tobacco Menace and What can Be Done About It 2Health News:Tobacco Menace and What can Be Done About It 3Health News:Tobacco Menace and What can Be Done About It 4Health News:Combination Therapies Continue to Thrive Among Pharma Brands 2Health News:Dentists Need More Training in Oral Cancer Detection 2Health News:Dentists Need More Training in Oral Cancer Detection 3Health News:Scientists Create Fire-proof, Eco-friendly Plastic 2
... MaximEyes by First Insight is the ... records solution for eye care professionals. ... with Eyefinitys online servicesrequest VSP authorizations, ... MaximEyes offers EMR, scheduling, billing, demographics, ...
... software- RLISYS provides a ... Support, and Training exclusively ... Ophthalmology, and Opticianry- The ... allowing you to focus ...
... The Advia 120 hematology ... streamline laboratory workflow and ... This analyzer offers a ... assays, meeting the needs ...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....
Medicine Products: